This ticker has not been starred yet CYTK Cytokinetics Inc
Pharmaceutical Preparations
Book value per $ invested $ -0.00
Leverage 100.97%
Market Cap $ 5.1B
PE 0.00
Dividend Yield 0.00%
Profit $ -571.6m
Margin -3132.77%

Cytokinetics, Incorporated, an advanced stage biopharmaceutical company, focuses on discovering, developing and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company is headquartered in South San Francisco, California.

Subscribe Now For Access - Only $1.99 Per Month